According to the World Health Organization reports, nowadays burden of chronic kidney diseases (CKD) is well documented. The high prevalence of noncommunicable diseases (NCD) such as hypertension, diabetes, and obesity, which are the main causes of CKD, is a big concern in the world health scenario [1]. These NCD can progress slowly to end-stage renal disease (ESRD) and the low-middle income countries (LMIC) like Haiti are not left unscathed by this worldwide scourge. Several well-known public health issues prevalent in Haiti such as acute diarrheal infections, malaria, tuberculosis, cholera, and acquired immunodeficiency syndrome (AIDS), can also impair the function of the kidney. Dialysis, a form of renal replacement therapy (RRT), represents a life-saving therapy for all patients affected with impaired kidney. In Haiti, few patients have access to health insurance or disability financial support. Considering that seventy-two percent (72%) of Haitians live with less than USD 2 per day [2], survival with CKD can be quite stressful for them. Data on the weight of the dialysis and its management are scarce. Addressing the need for dialysis in Haiti is an important component in decision-making and planning processes in the health sector. This paper is intended to bring forth discussion on the use of this type of renal replacement therapy in Haiti: the past, the present, and the challenges it presents. We will also make some recommendations in order to manage this serious problem.

Keywords:
Chronic kidney disease, Renal replacement therapy, Dialysis, Low-middle income countries, Haiti
1.
World Health Organisation: http://www.who.int/healthinfo/global_burden_disease/gbd/en/ (retrieved August 30, 2014).
2.
Health National planning 2012. Ministère de la santé publique et de la population (http://www.nationalplanningcycles.org/sites/default/files/country_docs/Haiti/haiti_politique_national_de_sante_2012.pdf (retrieved August 30, 2014).
3.
Schieppati A, Remuzzi G: Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int Suppl 2005;98:S7-S10.
4.
Gregory MC: Cost-effective dialysis for the developing world. Ethn Dis 2009;19:65-67.
5.
Exantus J: Néphrologie pédiatrique dans les pays en voie de développement; in Cochat P, Bérard TE (eds): Néphrologie pédiatrique. Progrès en pédiatrie. Ruel-Malmaison, Doin, 2011, pp 82-86.
6.
Bello BT, Raji YR, Sanusi I, Braimoh RW, Amira OC, Mabayoje OM: Challenges of providing maintenance hemodialysis in a resource poor country: experience from a single teaching hospital in Lagos, Southwest Nigeria. Hemodial Int 2013;17:427-433.
7.
Okunola O, Akinsola A, Ayodele O: Kidney diseases in Africa: aetiological considerations, peculiarities and burden. Afr J Med Med Sci 2012;41:119-133.
8.
Jean-Baptiste ED, Larco P, Charles-Larco N, Vilgrain C, Simon D, Charles R: Glucose intolerance and other cardiovascular risk factors in Haiti. Prevalence of Diabetes and Hypertension in Haiti (PREDIAH). Diabetes Metab 2006;32:443-451.
9.
Neil N, Walker DR, Sesso R, et al: Gaining efficiencies: resources and demand for dialysis around the globe. Value Health 2009;12:73-79.
10.
Soyibo AK, Barton EN: Report from the Caribbean renal registry, 2006. West Indian Med J 2007;56:355-363.
11.
Modi GK, Jha V: The incidence of end-stage renal disease in India: a population-based study. Kidney Int 2006;70:2131-2133.
12.
Cochat P, Mourani C, Exantus J, Bourquia A, Martinez-Pico M, Adonis-Koffy L, Bacchetta J: Néphrologie pédiatrique dans les pays en développement. Med Trop 2009;69:543-547.
13.
Harambat J, van Stralen KJ, Kim JJ, Tizard EJ: Epidemiology of chronic kidney disease in children. Pediatr Nephrol 2012;27:363-373.
14.
Warady BA, Chadha V: Chronic kidney disease in children: the global perspective. Pediatr Nephrol 2007;22:1999-2009.
15.
Ladapo TA, Esezobor CI, Lesi FE: Pediatric kidney diseases in an African country: prevalence, spectrum and outcome. Saudi J Kidney Dis Transpl 2014;25:1110-1116.
16.
Doyon A, Schaefer F: The prodromal phase of obesity-related chronic kidney disease: early alterations in cardiovascular and renal function in obese children and adolescents. Nephrol Dial Transplant 2013;28:50-57.
17.
Kelishadi R, Gheissari A, Bazookar N, Motlagh ME, Taslimi M, Ardalan G: Kidney function in obese adolescents with or without metabolic syndrome in a nationally-representative sample of pediatric population: first report from the Middle East and North Africa: The CASPIAN-III Study: A Case-Control Study. J Res Med Sci 2013;18:178-183.
18.
Guinhouya BC: Physical activity in preventing metabolic syndrome in children. Med Sci 2009;25:827-833.
19.
Promoting nutrition security in Haiti: An assessment of pre- and post-earthquake conditions and recommendations for the way forward. World Bank Report, September 2010.
20.
Pan-American Health Organization: Malnutrition in Infants and Young children in Latin America and the Caribbean: Achieving the Millennium Development Goals. http://siteresources.worldbank.org/NUTRITION/Resources/HaitiNutritionAssessmentEnglishFINAL.pdf2008.
21.
Ruiz-Narváez EA, Palmer JR, Gerlovin H, Wise LA, Vimalananda VG, Rosenzweig JL, Rosenberg L: Birth weight and risk of type 2 diabetes in the black women's health study: does adult BMI play a mediating role? Diabetes Care 2014;37:2572-2578.
22.
Ehrich JH, Eke FU: Malaria-induced renal damage: facts and myths. Pediatr Nephrol 2007;22:626-637.
23.
Anochie IC, Eke FU: Acute renal failure in Nigerian children: Port Harcourt experience. Pediatr Nephrol 2005;20:1610-1614.
24.
O'Brien KL, Selanikio JD, Hecdivert C, Placide MF, Louis M, Barr DB, Barr JR, Hospedales CJ, Lewis MJ, Schwartz B, Philen RM, St Victor S, Espindola J, Needham LL, Denerville K: Epidemic of pediatric deaths from acute renal failure caused by diethylene glycol poisoning. Acute Renal Failure Investigation Team. JAMA 1998;279:1175-1180.
25.
Hogan M: In Haiti, Nephrologists on the Ground Report Challenges and Successes in Treating Earthquake Victims. Nephrology Times 2010, DOI: 10.1097/01.NEP.0000369176.25674.a1.
26.
Hattori S, Yosioka K, Honda M, Ito H: The 1998 report of the Japanese National Registry data on pediatric end-stage renal disease patients. Pediatr Nephrol 2002;17:456-461.
27.
Fadrowski JJ, Frankenfield D, Amaral S, Brady T, Gorman GH, Warady B, Furth SL, Fivush B, Neu AM: Children on long-term dialysis in the United States: findings from the 2005 ESRD clinical performance measures project. Am J Kidney Dis 2007;50:958-966.
28.
Odetunde OI, Okafor HU, Uwaezuoke SN, Ezeonwu BU, Adiele KD, Ukoha OM: Chronic kidney disease in children as seen in a tertiary hospital in Enugu, South-East, Nigeria. Niger J Clin Pract 2014;17:196-200.
29.
White S, et al: How can we achieve global equity in provision of renal replacement therapy? Bull World Health Organ 2008;86:229-237.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.